Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VolitionRX Limited Common Stock (NY:VNRX)

0.3374 -0.0125 (-3.57%)
Streaming Delayed Price Updated: 12:39 PM EDT, Sep 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about VolitionRX Limited Common Stock

< Previous 1 2 3 4 5 6 Next >
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
On Friday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-08-27: top gainers and losers in today's session. ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers VolitionRX (AMEX:VNRX) shares increased by 102.2% to $0.69 during Thursday's pre-market session. The company's market cap stands at $4.8 million. NewcelX (NASDAQ:NCEL) shares increased by... 
Via Benzinga
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Nu.Q NETs H3.1 Study Reports Predictive Value in Sepsis
Via Investor Brand Network
News headline image
Volition (VNRX) Q2 2026 Earnings Call Transcript ↗
Revenue flat as cost cuts narrowed losses and cash strengthened. 
Via The Motley Fool
Topics Death Earnings
News headline image
VolitionRX Reports Q2 2026 Results: Full Earnings Call Transcript ↗
On Friday, VolitionRX (AMEX:VNRX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call... 
Via Benzinga
Topics Earnings
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Reports Strong Correlation for Finger-Prick Nu.Q NETs Prototype in Sepsis Patients
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Publishes Peer-Reviewed Capture-Seq Study
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Highlights Growing Clinical Evidence Supporting Nu.Q NETs Test
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Study Highlights Prognostic Value of Nu.Q Cancer Assay in Lung Cancer
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Collaborates with Sysmex to Advance Nu.Q® NETs Assay Development
Via Investor Brand Network
BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Expands Patent Portfolio with Ebola Triage Application
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Highlights Clinical and Commercial Progress Across Diagnostics Portfolio
Via Investor Brand Network
News headline image
BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Reports High Accuracy In Feline Cancer Blood Test Study
Via Investor Brand Network
InvestorNewsBreaks – VolitionRx Ltd. (NYSE American: VNRX) Reports Finger-Prick Breakthrough for Nucleosome Detection in Sepsis
Via Investor Brand Network
Which stocks are most active on Wednesday? ↗
Via Chartmill
These stocks have an unusual volume in today's session ↗
Via Chartmill
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Over 95% Early-Stage Cancer Detection Using Capture-Seq Technology
Via Investor Brand Network
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Breakthrough in Liquid Biopsy With Over 99% Cancer DNA Purity
Via Investor Brand Network
News headline image
Why VNRX Stock Is Soaring Over 70% In Pre-Market Today? ↗
The company said it can isolate nearly pure tumor DNA from blood, which potentially solves a key bottleneck in liquid biopsy. 
Via Stocktwits
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.